Sign Out
Norplat: For the prevention of atherosclerotic events in peripheral arterial disease or within 35 days of myocardial infarction or within 6 months of ischemic stroke or in acute coronary syndrome without ST-segment elevation.
Norplat-S: Reduction of thrombotic events in patients with recent myocardial infarction, recent stroke or established peripheral arterial disease.
Prophylactically in patients at risk of thromboembolic disorders eg, myocardial infarction, peripheral arterial disease and stroke.
Acute coronary syndrome (unstable angina/non-Q wave myocardial infarction).
